Home › Incyte Announces Top-Line Results From RELIEF Trial Of Ruxolitinib In Patients With Polycythemia Vera
 

Keywords :   


Incyte Announces Top-Line Results From RELIEF Trial Of Ruxolitinib In Patients With Polycythemia Vera

2014-07-30 09:39:10| drugdiscoveryonline Home Page

Incyte Corporation recently announced top-line results from RELIEF, a randomized, double-blind clinical trial designed to compare symptom improvement in 110 patients with polycythemia vera (PV) treated with ruxolitinib versus patients treated with hydroxyurea (HU)

Tags: with results trial patients

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Five more San Antonio TV stations launch NEXTGEN TV
15.05Liberty Latin America organic Video RGUs up 2,000 in 1Q 2024
15.05Dine and dash couple hit my pizzeria, says owner
15.05Boeing may face criminal prosecution, US says
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
More »